Susan Williamson

Susan Williamson will serve as Chief Compliance Officer for the combined company following the close of the transaction. She has served as Senior Vice President and Chief Compliance Officer of Endo, Inc. and its predecessor Endo International plc since April 2018. In this role, she is responsible for the strategic direction and operations of the company’s Global Corporate Compliance program.

Ms. Williamson joined Endo in 2012 and has been a valued member of Endo's Corporate Compliance leadership team, previously serving as Vice President and U.S. and Canadian Compliance Officer where she was responsible for oversight of the company’s Corporate Compliance program, including management of its Corporate Integrity Agreement (CIA), enterprise-wide corporate compliance training and monitoring, and Aggregate Spend reporting.

Prior to joining Endo, Ms. Williamson worked at Pfizer in Operational Risk Management supporting Pfizer’s CIA from 2009 to 2012. Prior to her employment with Pfizer, Ms. Williamson spent over five years at Wyeth Pharmaceuticals and held key roles in building, developing, and implementing a Global Corporate Compliance program.

Ms. Williamson began her career in public accounting at Ernst & Young in the Assurance and Advisory Practice. Ms. Williamson is a Certified Public Accountant and holds a Bachelor of Science degree in Accounting from Saint Joseph’s University as well as a Master of Business Administration from the Erivan K. Haub School of Business at St. Joseph’s University.